149 related articles for article (PubMed ID: 1714756)
1. Effects of recombinant human granulocyte colony-stimulating factor on leucopenia in zidovudine-treated patients with AIDS and AIDS related complex, a phase I/II study.
van der Wouw PA; van Leeuwen R; van Oers RH; Lange JM; Danner SA
Br J Haematol; 1991 Jul; 78(3):319-24. PubMed ID: 1714756
[TBL] [Abstract][Full Text] [Related]
2. Recombinant human granulocyte-macrophage colony-stimulating factor ameliorates zidovudine-induced neutropenia in patients with acquired immunodeficiency syndrome (AIDS)/AIDS-related complex.
Levine JD; Allan JD; Tessitore JH; Falcone N; Galasso F; Israel RJ; Groopman JE
Blood; 1991 Dec; 78(12):3148-54. PubMed ID: 1742482
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of granulocyte colony-stimulating factor (G-CSF) on neutropenia in zidovudine-treated patients with AIDS and ARC: a preliminary report.
Garavelli PL
Haematologica; 1992; 77(3):293-4. PubMed ID: 1385275
[No Abstract] [Full Text] [Related]
4. Combined therapy with recombinant granulocyte colony-stimulating factor and erythropoietin decreases hematologic toxicity from zidovudine.
Miles SA; Mitsuyasu RT; Moreno J; Baldwin G; Alton NK; Souza L; Glaspy JA
Blood; 1991 May; 77(10):2109-17. PubMed ID: 1709368
[TBL] [Abstract][Full Text] [Related]
5. Recombinant granulocyte colony-stimulating factor (rG-CSF) in HIV patients with zidovudine related neutropenia.
Clumeck N; Wit SD; Hermans P; Franchioly P; Sommereijns B
J Nutr Sci Vitaminol (Tokyo); 1992; Spec No():353-6. PubMed ID: 1284305
[No Abstract] [Full Text] [Related]
6. Efficacy of recombinant human granulocyte colony-stimulating factor on neutropenia in patients with AIDS.
Kimura S; Matsuda J; Ikematsu S; Miyazono K; Ito A; Nakahata T; Minamitani M; Shimada K; Shiokawa Y; Takaku F
AIDS; 1990 Dec; 4(12):1251-5. PubMed ID: 1708265
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and pharmacodynamics of granulocyte-macrophage colony-stimulating factor and zidovudine in patients with AIDS and severe AIDS-related complex.
Hewitt RG; Morse GD; Lawrence WD; Maliszewski ML; Santora J; Bartos L; Bonnem E; Poiesz B
Antimicrob Agents Chemother; 1993 Mar; 37(3):512-22. PubMed ID: 8460920
[TBL] [Abstract][Full Text] [Related]
8. Interferon-alpha, zidovudine, and granulocyte-macrophage colony-stimulating factor: a phase I AIDS Clinical Trials Group study in patients with Kaposi's sarcoma associated with AIDS.
Krown SE; Paredes J; Bundow D; Polsky B; Gold JW; Flomenberg N
J Clin Oncol; 1992 Aug; 10(8):1344-51. PubMed ID: 1634925
[TBL] [Abstract][Full Text] [Related]
9. Granulocyte colony-stimulating factor treatment in AIDS patients.
Hengge UR; Brockmeyer NH; Goos M
Clin Investig; 1992 Oct; 70(10):922-6. PubMed ID: 1280496
[TBL] [Abstract][Full Text] [Related]
10. [Recombinant granulocyte colony-stimulating factor in the long-term treatment of AIDS-related neutropenias].
Garavelli PL; Berti P
Recenti Prog Med; 1993; 84(7-8):526-30. PubMed ID: 8356307
[TBL] [Abstract][Full Text] [Related]
11. Therapy for neutropenia in hairy cell leukemia with recombinant human granulocyte colony-stimulating factor.
Glaspy JA; Baldwin GC; Robertson PA; Souza L; Vincent M; Ambersley J; Golde DW
Ann Intern Med; 1988 Nov; 109(10):789-95. PubMed ID: 2461131
[TBL] [Abstract][Full Text] [Related]
12. Recombinant human granulocyte colony-stimulating factor increases circulating CD34-postive cells in patients with AIDS.
Nielsen SD; Dam-Larsen S; Nielsen C; Wantzia P; Mathiesen L; Hansen JE
Ann Hematol; 1997 May; 74(5):215-20. PubMed ID: 9200993
[TBL] [Abstract][Full Text] [Related]
13. A phase I/II trial of zidovudine, interferon-alpha, and granulocyte-macrophage colony-stimulating factor in the treatment of human immunodeficiency virus type 1 infection.
Davey RT; Davey VJ; Metcalf JA; Zurlo JJ; Kovacs JA; Falloon J; Polis MA; Zunich KM; Masur H; Lane HC
J Infect Dis; 1991 Jul; 164(1):43-52. PubMed ID: 1676045
[TBL] [Abstract][Full Text] [Related]
14. Treatment of hairy cell leukemia with granulocyte colony-stimulating factor and recombinant consensus interferon or recombinant interferon-alpha-2b.
Glaspy JA; Souza L; Scates S; Narachi M; Blatt L; Ambersley J; Golde DW
J Immunother (1991); 1992 Apr; 11(3):198-208. PubMed ID: 1381218
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of chemotherapy-induced neutropenia pegylated recombinant human granulocyte colony-stimulating factor: a multi-center randomized controlled phase II clinical study].
Shi YK; He XH; Yang S; Wang HQ; Jiang ZF; Zhu YZ; Ke XY; Zhang Y; Liu YP; Zhang WJ; Wang Z; Shi QZ; Xie XD; Zhang HL; Wang JJ; Luo DY; Zheng QS; Sun RY
Zhonghua Yi Xue Za Zhi; 2006 Dec; 86(48):3414-9. PubMed ID: 17313855
[TBL] [Abstract][Full Text] [Related]
16. Combination treatment with azidothymidine and granulocyte colony-stimulating factor in children with human immunodeficiency virus infection.
Mueller BU; Jacobsen F; Butler KM; Husson RN; Lewis LL; Pizzo PA
J Pediatr; 1992 Nov; 121(5 Pt 1):797-802. PubMed ID: 1279153
[TBL] [Abstract][Full Text] [Related]
17. Granulocyte and granulocyte-macrophage colony-stimulating factors for treatment of neutropenia in glycogen storage disease type Ib.
Schroten H; Roesler J; Breidenbach T; Wendel U; Elsner J; Schweitzer S; Zeidler C; Burdach S; Lohmann-Matthes ML; Wahn V
J Pediatr; 1991 Nov; 119(5):748-54. PubMed ID: 1719175
[TBL] [Abstract][Full Text] [Related]
18. Subcutaneous recombinant granulocyte-macrophage colony-stimulating factor used as a single agent and in an alternating regimen with azidothymidine in leukopenic patients with severe human immunodeficiency virus infection.
Pluda JM; Yarchoan R; Smith PD; McAtee N; Shay LE; Oette D; Maha M; Wahl SM; Myers CE; Broder S
Blood; 1990 Aug; 76(3):463-72. PubMed ID: 2198957
[TBL] [Abstract][Full Text] [Related]
19. Granulocyte-macrophage colony-stimulating factor mitigates the neutropenia of combined interferon alfa and zidovudine treatment of acquired immune deficiency syndrome-associated Kaposi's sarcoma.
Scadden DT; Bering HA; Levine JD; Bresnahan J; Evans L; Epstein C; Groopman JE
J Clin Oncol; 1991 May; 9(5):802-8. PubMed ID: 2016623
[TBL] [Abstract][Full Text] [Related]
20. Zidovudine treatment of patients with acquired immune deficiency syndrome and acquired immune deficiency syndrome-related complex: St Stephen's Hospital experience.
Stambuk D; Hawkins D; Gazzard BG
J Infect; 1989 Jan; 18 Suppl 1():41-51. PubMed ID: 2492585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
